ライフサイエンスコーパス: coronary calcification

1 ss with an osteoblastic component resembling coronary calcification.

2 enuates the effects of insulin resistance on coronary calcification.

3 ilable and is limited in patients with dense coronary calcification.

4 nce daily) did not affect the progression of coronary calcification.

5 py but did not result in less progression of coronary calcification.

6 ween antibodies to human HSP60 and levels of coronary calcification.

7 ose-response manner, with elevated levels of coronary calcification.

8 igh CRP levels are associated with increased coronary calcification.

9 imarily to detect and quantify the extent of coronary calcification.

10 ommon in femoral arteries (54%), followed by coronary calcification (38%) and carotid plaques (34%).

11 From a total of 383 vessels without any coronary calcification, 47 (12%) presented with >or=50%

12 on, coronary heart disease risk factors, and coronary calcification (a marker of atherosclerosis) wer

13 There is substantial evidence that coronary calcification, a marker for the presence and qu

14 ee survival is also reduced in patients with coronary calcification after both percutaneous coronary

15 The prevalence of coronary calcification (Agatston score >0) in these 4 et

16 ght to determine the frequency and impact of coronary calcification among patients undergoing percuta

17 After similar adjustments, the amount of coronary calcification among those with an Agatston scor

18 no large population-based studies comparing coronary calcification among US ethnic groups.

19 studies showing strong correlations between coronary calcification and coronary heart disease events

20 HSP65 are associated with elevated levels of coronary calcification and correlated with H pylori infe

21 r prevention of hyperphosphatemia may reduce coronary calcification and its associated morbidity and

22 our understanding of the pathophysiology of coronary calcification and its clinical significance.

23 sought to determine the relationship between coronary calcification and plaque progression in respons

24 xamined cross-sectional associations between coronary calcification and potential risk factors in hea

25 y and antioxidants retard the progression of coronary calcification and prevent atherosclerotic cardi

26 lipid-lowering therapy slows progression of coronary calcification and prevents coronary artery dise

27 e diabetes therapy reduces the prevalence of coronary calcification and progression of atherosclerosi

28 be worth investigating the relation between coronary calcification and risk factors not quantified i

29 s of the proximal coronary arteries, detects coronary calcifications and has been demonstrated to be

30 computed tomography to assess the number of coronary calcifications and the coronary artery calcific

31 he 10-year Framingham risk index, histologic coronary calcification, and culprit plaque morphology in

32 nsibility; 2) aortic pulse wave velocity; 3) coronary calcification; and 4) brachial artery endotheli

33 er consensus on criteria for abnormality for coronary calcification are advised.

34 Framingham risk index and the measurement of coronary calcification are distinct methods of assessing

35 This may justify the use of coronary calcification as a surrogate marker for coronar

36 a single imaging session, and the volume of coronary calcification as quantified with this technique

37 e risk for coronary artery disease underwent coronary calcification assessment with cardiac CT angiog

38 omputed tomography (EBCT) is used to measure coronary calcification but not for aortic valve calcific

39 thy by evaluating heart failure patients for coronary calcification (CC).

40 orldwide, are associated with progression in coronary calcification, consistent with acceleration of

41 The relation among coronary calcification, coronary stenoses and coronary h

42 Intravascular ultrasound analysis shows that coronary calcification correlates with plaque burden but

43 Coronary calcification correlates with the extent of ath

44 This review examines the power of coronary calcification detected by electron beam compute

45 Coronary calcification detected by electron beam compute

46 ention studies can use the rate of change of coronary calcification detected by serial electron beam

47 Coronary calcification determined by electron beam compu

48 The absence of coronary calcification does not exclude obstructive sten

49 beam CT scans were obtained in patients with coronary calcification (group A) or known risk factors f

50 lar, left main CAD (h2=0.49+/-0.12; P=0.01), coronary calcification (h2=0.51+/-0.17; P=0.001), and ec

51 The predictive power of coronary calcification has been shown to exceed that of

52 Most data on coronary calcification have been obtained with electron-

53 Efforts to refine statin eligibility via coronary calcification have been studied in white popula

54 Using computed tomography, we measured coronary calcification in 6814 white, black, Hispanic, a

55 ronic stress burden were not associated with coronary calcification in a multiethnic sample of asympt

56 risk factor-adjusted relative prevalences of coronary calcification in men for the top fourth categor

57 (> or = 14 drinks/week) was associated with coronary calcification in other race/sex subgroups.

58 ; p = 0.025) or when we further adjusted for coronary calcification in participants with positive Aga

59 inflammatory mediators with the severity of coronary calcification in RA and control subjects was ex

60 on may explain why type 1 diabetes increases coronary calcification in women relatively more than in

61 of future cardiac events, presumably because coronary calcification is a marker for overall atheroscl

62 Although coronary calcification is associated with worse cardiova

63 The prevalence and severity of coronary calcification is increased in patients with est

64 sociation of mHSP65 antibodies with elevated coronary calcification levels was independent of CAD ris

65 e investigators believe that the presence of coronary calcification may stabilize the atherosclerotic

66 (mean age, 42 years; 79% male; 66 [15%] had coronary calcification; mean [SD] predicted 10-year coro

67 verity, distribution of lesions, presence of coronary calcification, morphology of stenoses, and anat

68 e in FRS, after controlling for knowledge of coronary calcification, motivation for change, and multi

69 tricted the analysis to participants without coronary calcification (n = 222; OR: 4.77; 95% CI: 1.22

70 Little is known about the impact of coronary calcification on outcomes after PCI for patient

71 l fibrillation, but not for high heart rate, coronary calcification, or obesity.

72 VLDL size were significantly associated with coronary calcification (P = 0.001, 0.02, and 0.04, respe

73 plaque erosion (n=22) had significantly less coronary calcification (P=0.003) and lower Framingham ri

74 The extent and progression of coronary calcification predict cardiovascular events.

75 Coronary calcification quantified by EBCT is closely rel

76 gham risk index and the extent of histologic coronary calcification (r=0.35, P=0.002).

77 centrations attenuated the increased risk of coronary calcification related to insulin resistance.

78 nt pre-test probabilities and in presence of coronary calcification remains uncertain.

79 or women with none, minimal, and significant coronary calcification, respectively.

80 = 0.50), CRP (rho = 0.29), ESR (rho = 0.26), coronary calcification (rho = 0.26), and Disease Activit

81 ded to establish the predictive power of the coronary calcification score for clinical events and the

82 Leslee Shaw and colleagues showed that the coronary calcification score predicted total mortality w

83 There was no correlation between the coronary-calcification score and the scores measuring de

84 Using coronary calcification screening to motivate patients to

85 ars to be comparable to electron-beam CT for coronary calcification screening, except in subjects wit

86 ents for identification and/or management of coronary calcification, stenotic or obstructive disease,

87 P65 antibodies are associated with levels of coronary calcification that appear to reflect preclinica

88 differences in the presence and quantity of coronary calcification that were not explained by corona

89 he coronary arteries and the relationship of coronary calcification to standard coronary disease risk

90 ce of coronary atherosclerosis by imaging of coronary calcification using cardiac computed tomography

91 We measured coronary calcification using electron-beam dual-source c

92 Quantification of coronary calcification via electron beam computed tomogr

93 present sample, the odds ratio of having any coronary calcification was 2.57 (95% confidence interval

94 up (55% women, 45% Black), the prevalence of coronary calcification was 8% for consumption of 0 drink

95 In this prospective cohort, the presence of coronary calcification was associated with an independen

96 yesian network that predicts the presence of coronary calcification was constructed.

97 ts had significant angiographic disease, and coronary calcification was detected in 404, yielding a s

98 The presence of coronary calcification was evaluated.

99 The extent of coronary calcification was more pronounced with older ag

100 Coronary calcification was present in one patient who ha

101 Coronary calcification was the major cause of false-posi

102 d with whites, the relative risks for having coronary calcification were 0.78 (95% CI 0.74 to 0.82) i

103 The mean patient age and prevalence of coronary calcification were similar in the 2 groups (53+

104 CAC score and number of coronary calcifications were directly related to age-adj

105 clerosis (MESA), a population-based study of coronary calcification, were used to investigate accultu

106 and socioeconomic position as predictors of coronary calcification within 2553 non-Hispanic whites,

107 differences in the prevalence and amount of coronary calcification within whites, Chinese, blacks, a